PRME
Price
$1.67
Change
+$0.31 (+22.79%)
Updated
Jun 6, 04:36 PM (EDT)
Capitalization
179.87M
61 days until earnings call
TCRX
Price
$1.80
Change
+$0.12 (+7.14%)
Updated
Jun 6, 04:41 PM (EDT)
Capitalization
93.94M
68 days until earnings call
Interact to see
Advertisement

PRME vs TCRX

Header iconPRME vs TCRX Comparison
Open Charts PRME vs TCRXBanner chart's image
Prime Medicine
Price$1.67
Change+$0.31 (+22.79%)
Volume$1.97K
Capitalization179.87M
TScan Therapeutics
Price$1.80
Change+$0.12 (+7.14%)
Volume$100
Capitalization93.94M
PRME vs TCRX Comparison Chart
Loading...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PRME vs. TCRX commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PRME is a StrongBuy and TCRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (PRME: $1.37 vs. TCRX: $1.66)
Brand notoriety: PRME and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PRME: 167% vs. TCRX: 34%
Market capitalization -- PRME: $179.87M vs. TCRX: $93.94M
PRME [@Biotechnology] is valued at $179.87M. TCRX’s [@Biotechnology] market capitalization is $93.94M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PRME’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • PRME’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, TCRX is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PRME’s TA Score shows that 3 TA indicator(s) are bullish while TCRX’s TA Score has 5 bullish TA indicator(s).

  • PRME’s TA Score: 3 bullish, 3 bearish.
  • TCRX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, both PRME and TCRX are a good buy in the short-term.

Price Growth

PRME (@Biotechnology) experienced а +8.73% price change this week, while TCRX (@Biotechnology) price change was +12.93% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.55%. For the same industry, the average monthly price growth was +17.24%, and the average quarterly price growth was +3.49%.

Reported Earning Dates

PRME is expected to report earnings on Aug 06, 2025.

TCRX is expected to report earnings on Aug 13, 2025.

Industries' Descriptions

@Biotechnology (+11.55% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($180M) has a higher market cap than TCRX($93.9M). TCRX YTD gains are higher at: -45.395 vs. PRME (-53.082). TCRX has higher annual earnings (EBITDA): -124.58M vs. PRME (-200M). TCRX has more cash in the bank: 252M vs. PRME (144M). TCRX has less debt than PRME: TCRX (97M) vs PRME (121M). TCRX has higher revenues than PRME: TCRX (4.42M) vs PRME (3.85M).
PRMETCRXPRME / TCRX
Capitalization180M93.9M192%
EBITDA-200M-124.58M161%
Gain YTD-53.082-45.395117%
P/E RatioN/AN/A-
Revenue3.85M4.42M87%
Total Cash144M252M57%
Total Debt121M97M125%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
37
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PRMETCRX
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
82%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
89%
Bearish Trend 24 days ago
90%
BollingerBands
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
THOCX39.670.21
+0.53%
Thornburg Global Opportunities C
QLSGX27.35N/A
N/A
Federated Hermes MDT Small Cap Growth R6
OLVRX20.13N/A
N/A
JPMorgan Large Cap Value R4
VDMCX9.92N/A
N/A
Virtus KAR Developing Markets C
ASQIX15.57N/A
N/A
American Century Small Company Inv

PRME and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRME has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PRME jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRME
1D Price
Change %
PRME100%
+3.79%
CRSP - PRME
63%
Loosely correlated
+1.37%
RXRX - PRME
56%
Loosely correlated
-7.13%
BEAM - PRME
56%
Loosely correlated
-0.87%
ABCL - PRME
51%
Loosely correlated
-2.27%
CCCC - PRME
50%
Loosely correlated
-4.87%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with IMNM. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-6.74%
IMNM - TCRX
46%
Loosely correlated
+1.16%
FATE - TCRX
45%
Loosely correlated
-5.63%
MGNX - TCRX
43%
Loosely correlated
-3.33%
PRME - TCRX
42%
Loosely correlated
+3.79%
STRO - TCRX
42%
Loosely correlated
-9.37%
More